Sort
51,593 grants matching “hepatitis”
Search For New and Emerging Etiologic Agents
$963,661Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
$963,581Alberto Gandini · Accel Diagnostics, Llc · R44 · FY2022 · AI
THE SOUTHEASTERN COOPERATIVE HEPATITIS C RESEARCH GROUP
$963,535University Of Texas Medical Br Galveston · U19 · FY2001 · AI
GENERAL CLINICAL RESEARCH CENTER
$963,534University Of Kentucky · M01 · FY2000 · RR
Innate immunity and cytokines in liver diseases
$963,239Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2017 · AA
Risk Stratification for and Early Detection of Liver Cancer
$963,046Fasiha Kanwal · Baylor College Of Medicine · U01 · FY2023 · CA
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$962,941Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2022 · AA
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$962,513Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$962,471Wendy S Post · Johns Hopkins University · R01 · FY2009 · HL
DCTD Human Toxicology and Pharmacology
$962,236David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
Development of a host-targeted antiviral as a chronic hepatitis B therapeutic with potential to achieve a functional cure
$961,797Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2024 · AI
Development of a host-targeted antiviral as a chronic hepatitis B therapeutic with potential to achieve a functional cure
$961,797Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2025 · AI
HBI-002 to Treat Diabetic Retinopathy
$961,240Edward Gomperts · Hillhurst Biopharmaceuticals, Inc. · R44 · FY2025 · EY
High Tc susceptometer for magnetic measure of body iron
$960,533Columbia University Health Sciences · R01 · FY2005 · DK
Endothelial Dysfunction, Oxidative Stress and Risk of Peripheral Arterial Disease
$960,414Kenneth Jay Mukamal · Beth Israel Deaconess Medical Center · R01 · FY2010 · HL
Asian Community Cancer Health Disparities Center (ACCHDC)
$960,300Grace X Ma · Temple Univ Of The Commonwealth · U54 · FY2012 · CA
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$960,291Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
HCV replication and immunity
$960,172Research Inst Nationwide Children'S Hosp · U19 · FY2002 · AI
Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease
$959,860Rima F Kaddurah-Daouk · Duke University · U19 · FY2023 · AG
Riluzole Prodrugs for Melanoma and ALS
$959,604Allen Bernard Reitz · Fox Chase Chemical Diversity Center, Inc · R44 · FY2014 · CA
The Development of a Web-based Data Retrieval System for HIV Therapy Guidance
$958,725Christos J Petropoulos · Monogram Biosciences, Inc. · R44 · FY2009 · AI
Hepatocyte Transplantation for Liver Based Metabolic Disease
$958,429Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Hepatocyte Transplantation for Liver Based Metabolic Disease
$958,429Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DK
Cooperative Center for the study of HCV antibody responses and vaccine antigens
$958,342Mansun Law · Scripps Research Institute, The · U19 · FY2016 · AI
Integrated analysis of HBV-specific CD4 T cell and B cell responses to define their role in chronic hepatitis B and HBV functional cure.
$957,683Georg Michael Lauer · Massachusetts General Hospital · R01 · FY2025 · AI